ARTICLE | Distillery Therapeutics
Chlorobenzamide-based activator of SOD3 to treat osteoarthritis
May 6, 2019 7:23 PM UTC
INDICATION: Osteoarthritis ...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Osteoarthritis ...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles